4
Changes in Ownership
Rapport Therapeutics, Inc. Filed Acc 0001193125-26-410734
Chief Operating Officer sold 10,000 shares at an average $33.19 ($331,856)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Gault Cheryl Chief Operating Officer | 2026-09-30 | Sale 10b5-1 | −7,925 | $33.04 | $261,813 | 141,989 | D: show line 1 in the form |
| Gault Cheryl Chief Operating Officer | 2026-09-30 | Sale 10b5-1 | −2,075 | $33.76 | $70,043 | 139,914 | D: show line 2 in the form |
| Open-market sales · 10,000 sh · avg $33.19 · $331,856 | |||||||
Loading xslF345X06/ownership.xml…